Summarized by Masters of Longevity from Longevity Technology.
A pivotal trial found Revita cut six-month weight regain versus sham.
Key Takeaways
- Revita preserved about 80% of tirzepatide-induced weight loss.
- Longer duodenal ablation was associated with less weight regain.
- Safety signals were favorable but the study is still ongoing.
